Staff & Wire Reports-UnitedHealth Group's Chair and CEO William W. McGuire, MD, has stepped down as chairman of the board and will resign as CEO on Dec. 1, following the release of a report that found that Dr. McGuire likely received backdated stock options.
STAFF & WIRE REPORTS-UnitedHealth Group's Chair and CEO William W. McGuire, MD, has stepped down as chairman of the board and will resign as CEO on Dec. 1, following the release of a report that found that Dr. McGuire likely received backdated stock options.
According to an Oct. 15 UnitedHealth Group company statement outlining a series of actions, the UnitedHealth Group Board elected Stephen J. Hemsley to succeed Dr. McGuire as CEO upon his departure from the company. Hemsley joined the company in 1997 and has been president and COO since 1999.
According to Clive Riddle, president and founder of MCOL, a provider of business-to-business health management and managed care resources, during Dr. McGuire's time at UnitedHealth, the company's stock increased a multiple of 56 times.
In February, a United press release announced Dr. McGuire's exercise of 2.3 million shares of stock to support philanthropic commitments and for financial diversification purposes, according to Riddle. "Never in a million years do I think Dr. McGuire or United imagined at that time, that they did anything wrong or that the transaction would help trigger the firestorm that it did," he says.
BIG FISH
"United got caught in the backdating scandal because they are a big and very visible fish," Riddle continues. "But there will be other large healthcare companies ultimately caught in this net as well. More importantly, most of the companies caught in this scandal have nothing to do with healthcare. You just have to be a public company, be fairly visible, have stock options and participated in a practice that has indeed been widespread to now operate under a cloud."
UnitedHealth Group could not be reached for comment.
With aging populations, osteoporosis rates are set to increase, and researchers are looking for the next innovative drug to help prevent or manage the bone disease as there is currently no drug that completely does so effectively, according to a recent study published in Advanced Science.
Read More
In this second part of a two-part podcast episode, Managed Healthcare Executive's Managing Editor Peter Wehrwein spoke with CeCi Connolly and Margaret "Meg" Murray about Medicare Advantage utilization and challenges, highlighting proposed CMS payment cuts and prior authorization issues.
Listen
In this first part of a two-part podcast episode, Managed Healthcare Executive's Managing Editor Peter Wehrwein kicks off our new podcast series "DC Roundtable," with guests Margaret "Meg" Murray, CEO of the Association of Community Affiliated Plans, and member of MHE's Editorial Advisory Board, and CeCi Connolly, president and CEO of the Alliance of Community Health Plans, for a discussion on healthcare policy issues.
Listen
What States are Doing to Regulate Pharmacy Benefit Managers
March 26th 2024In a poster presented at the 2024 American Pharmacists Association Annual Meeting and Exposition, researchers found that state-level PBM reform focused on more transparent drug pricing, better patient access to prescription drugs, and more stringent auditing and reporting requirements.
Read More